HillaryHWuMD

Oncology • Carmel, IN

Physician at Indiana University Health

Join to view full profile

Dr. Wu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wu's full profile

Already have an account?

Office
11645 Illinois St
Carmel, IN 46032
Phone+1 317-688-5964
Is this information wrong?

Education & Training

University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2000 - 2003
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1997 - 2000
Beijing Medical UniversityClass of 1987

Certifications & Licensure

IN State Medical License 2000 - 2025
CO State Medical License 2002 - 2023
NC State Medical License 2002 - 2019
AL State Medical License Active through 2018
WA State Medical License 2002 - 2013
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Indianapolis Monthly Castle Connolly, 2011, 2013
Top MD Consumers Checkbook

Clinical Trials

A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors Start of enrollment: 2011 Mar 01
Completed
Phase 1
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Start of enrollment: 2010 Jan 01
Completed
Phase 1, Phase 2
Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma Start of enrollment: 2010 Jul 01
Terminated
Phase 1, Phase 2
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma Start of enrollment: 2012 Jan 01
Completed
Phase 2
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2013 Jan 18
Active, not recruiting
Phase 2
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. Start of enrollment: 2013 May 14
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

8 citations
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluor...
Tracy Murray Stewart, Daniel D. Von Hoff, Michael L. Fitzgerald, Laurence J. Marton, Thomas E. Boyd, Paul Conkling, Lawrence Garbo, Robert M. Jotte, Donald A. Richards...> ;Cancer Chemotherapy and Pharmacology. 2021 Jan 1
Influences of Copper/Zinc-Loaded Montmorillonite on Growth Performance, Mineral Retention, Intestinal Morphology, Mucosa Antioxidant Capacity, and Cytokine Contents in...
Jiao, L. F.,Zhang, Q. H.,Wu, H.,Wang, C. C.,Cao, S. T.,Feng, J.,Hu, C. H.> ;Biol Trace Elem Res. 2018 Feb 23
11 citations
Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer
Donald A. Richards, David M. Loesch, Svetislava J. Vukelja, Hillary H. Wu, William J. Hyman, Jeffery Nieves, Yunfei Wang, Simin Hu, Oluwatoyin O. Shonukan, Datchen F. Tai> ;Investigational New Drugs. 2011 Oct 1
17 citations
Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
Hillary H. Wu, Moshe Talpaz, Richard E. Champlin, R R N Susan Pilat, Razelle Kurzrock> ;Cancer. 2003 Dec 1
Join now to see all

Hospital Affiliations

Community Hospital EastIndianapolis, Indiana
Indiana University Health North HospitalCarmel, Indiana
Riverview HealthNoblesville, Indiana
Ascension St. Vincent Carmel HospitalCarmel, Indiana